Redmile Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,257
Closed -$4.01M 89
2021
Q2
$4.01M Sell
24,257
-2,410
-9% -$399K 0.06% 81
2021
Q1
$5.14M Buy
+26,667
New +$5.14M 0.07% 80